PD
CGEM icon

Point72 (DIFC)’s Cullinan Oncology CGEM Stock Holding History

Point72 (DIFC)’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$21.1K Buy
+3,553
New +$26K ﹤0.01% 860
2025
Q1 		– Sell
-5,986
Closed -$72.9K – 1712
2024
Q4 		$72.9K Buy
+5,986
New +$86K ﹤0.01% 1060
2024
Q2 		– Sell
-1,273
Closed -$21.7K – 1508
2024
Q1 		$21.7K Buy
+1,273
New +$19.7K ﹤0.01% 1295

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Point72 (DIFC)'s CGEM Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Cullinan Oncology (CGEM) in Q3 2025: 3,553 shares worth $21.1K. The stake represents ﹤0.01% of the portfolio and ranks #860 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in CGEM as recently as Q4 2024.

Point72 (DIFC) first reported a position in CGEM in Q1 2024 and has held it in 3 quarters since. The position peaked at $72.9K in Q4 2024. 145 funds tracked by Wall St. Rank hold CGEM as of Q3 2025.

  • Point72 (DIFC) held 3,553 shares of Cullinan Oncology worth $21.1K as of Q3 2025.
  • Cullinan Oncology was a new Point72 (DIFC) position in Q3 2025.
  • Cullinan Oncology made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #860 holding.
  • Point72 (DIFC) first reported a position in Cullinan Oncology in Q1 2024 and has held it in 3 quarters since.
  • Point72 (DIFC)'s Cullinan Oncology position peaked at $72.9K in Q4 2024.
  • 145 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.